Clinical Trial Update: Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 Mayo Clinic trial evaluating GLP-1 agonists to improve physical and vascular health in obese postmenopausal women; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Obesity

Drugs mentioned

• GLP-1 agonists

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity, Menopause | Phase 4 | Status: ENROLLING_BY_INVITATION